Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer
The onset of chemo-resistant recurrence represents the principal cause of high-grade serous ovarian carcinoma (HGSOC) death. HGSOC masses are characterized by a hypoxic microenvironment, which contributes to the development of this chemo-resistant phenotype. Hypoxia regulated-miRNAs (HRMs) represent...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/13/3358 |
id |
doaj-1d3b154d273e495d93a72773d5314c75 |
---|---|
record_format |
Article |
spelling |
doaj-1d3b154d273e495d93a72773d5314c752021-07-15T15:32:07ZengMDPI AGCancers2072-66942021-07-01133358335810.3390/cancers13133358Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian CancerPaola Todeschini0Elisa Salviato1Chiara Romani2Vittoria Raimondi3Francesco Ciccarese4Federico Ferrari5Germana Tognon6Sergio Marchini7Maurizio D’Incalci8Laura Zanotti9Antonella Ravaggi10Franco Odicino11Enrico Sartori12Donna M. D’Agostino13Michele Samaja14Chiara Romualdi15Eliana Bignotti16Angelo Nocivelli’ Institute of Molecular Medicine, ASST Spedali Civili di Brescia, University of Brescia, 25121 Brescia, ItalyDepartment of Biology, University of Padua, 35122 Padua, ItalyAngelo Nocivelli’ Institute of Molecular Medicine, ASST Spedali Civili di Brescia, University of Brescia, 25121 Brescia, ItalyIstituto Oncologico Veneto IOV—IRCCS, 35128 Padua, ItalyIstituto Oncologico Veneto IOV—IRCCS, 35128 Padua, ItalyDivision of Obstetrics and Gynecology, ASST Spedali Civili di Brescia, 25123 Brescia, ItalyDivision of Obstetrics and Gynecology, ASST Spedali Civili di Brescia, 25123 Brescia, ItalyDepartment of Oncology, Istituto di Ricerche Farmacologiche Mario Negri, IRCCS, 20156 Milan, ItalyDepartment of Oncology, Istituto di Ricerche Farmacologiche Mario Negri, IRCCS, 20156 Milan, ItalyAngelo Nocivelli’ Institute of Molecular Medicine, ASST Spedali Civili di Brescia, University of Brescia, 25121 Brescia, ItalyAngelo Nocivelli’ Institute of Molecular Medicine, ASST Spedali Civili di Brescia, University of Brescia, 25121 Brescia, ItalyDivision of Obstetrics and Gynecology, ASST Spedali Civili di Brescia, 25123 Brescia, ItalyDivision of Obstetrics and Gynecology, ASST Spedali Civili di Brescia, 25123 Brescia, ItalyIstituto Oncologico Veneto IOV—IRCCS, 35128 Padua, ItalyDepartment of Health Science, University of Milan, 20122 Milan, ItalyDepartment of Biology, University of Padua, 35122 Padua, ItalyAngelo Nocivelli’ Institute of Molecular Medicine, ASST Spedali Civili di Brescia, University of Brescia, 25121 Brescia, ItalyThe onset of chemo-resistant recurrence represents the principal cause of high-grade serous ovarian carcinoma (HGSOC) death. HGSOC masses are characterized by a hypoxic microenvironment, which contributes to the development of this chemo-resistant phenotype. Hypoxia regulated-miRNAs (HRMs) represent a molecular response of cancer cells to hypoxia and are involved in tumor progression. We investigated the expression of HRMs using miRNA expression data from a total of 273 advanced-stage HGSOC samples. The miRNAs associated with chemoresistance and survival were validated by RT-qPCR and target prediction, and comparative pathway analysis was conducted for target gene identification. Analysis of miRNA expression profiles indicated miR-23a-3p and miR-181c-5p over-expression as associated with chemoresistance and poor PFS. RT-qPCR data confirmed upregulation of miR-23a-3p in tumors from chemoresistant HGSOC patients and its significant association with shorter PFS. In silico miR-23a-3p target prediction and comparative pathway analysis identified platinum drug resistance as the pathway with the highest number of miR-23a-3p target genes. Among them, APAF-1 emerged as the most promising, being downregulated in platinum-resistant patients and in HGSOC chemo-resistant cells. These results highlight miR-23a-3p as a potential biomarker for HGSOC platinum response and prognosis and the miR23a-3p/APAF1 axis as a possible target to overcome platinum-resistance.https://www.mdpi.com/2072-6694/13/13/3358miRNAhypoxiaovarian cancerplatinum responseprognostic markermiR-23a-3p |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Paola Todeschini Elisa Salviato Chiara Romani Vittoria Raimondi Francesco Ciccarese Federico Ferrari Germana Tognon Sergio Marchini Maurizio D’Incalci Laura Zanotti Antonella Ravaggi Franco Odicino Enrico Sartori Donna M. D’Agostino Michele Samaja Chiara Romualdi Eliana Bignotti |
spellingShingle |
Paola Todeschini Elisa Salviato Chiara Romani Vittoria Raimondi Francesco Ciccarese Federico Ferrari Germana Tognon Sergio Marchini Maurizio D’Incalci Laura Zanotti Antonella Ravaggi Franco Odicino Enrico Sartori Donna M. D’Agostino Michele Samaja Chiara Romualdi Eliana Bignotti Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer Cancers miRNA hypoxia ovarian cancer platinum response prognostic marker miR-23a-3p |
author_facet |
Paola Todeschini Elisa Salviato Chiara Romani Vittoria Raimondi Francesco Ciccarese Federico Ferrari Germana Tognon Sergio Marchini Maurizio D’Incalci Laura Zanotti Antonella Ravaggi Franco Odicino Enrico Sartori Donna M. D’Agostino Michele Samaja Chiara Romualdi Eliana Bignotti |
author_sort |
Paola Todeschini |
title |
Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer |
title_short |
Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer |
title_full |
Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer |
title_fullStr |
Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer |
title_full_unstemmed |
Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer |
title_sort |
comprehensive profiling of hypoxia-related mirnas identifies mir-23a-3p overexpression as a marker of platinum resistance and poor prognosis in high-grade serous ovarian cancer |
publisher |
MDPI AG |
series |
Cancers |
issn |
2072-6694 |
publishDate |
2021-07-01 |
description |
The onset of chemo-resistant recurrence represents the principal cause of high-grade serous ovarian carcinoma (HGSOC) death. HGSOC masses are characterized by a hypoxic microenvironment, which contributes to the development of this chemo-resistant phenotype. Hypoxia regulated-miRNAs (HRMs) represent a molecular response of cancer cells to hypoxia and are involved in tumor progression. We investigated the expression of HRMs using miRNA expression data from a total of 273 advanced-stage HGSOC samples. The miRNAs associated with chemoresistance and survival were validated by RT-qPCR and target prediction, and comparative pathway analysis was conducted for target gene identification. Analysis of miRNA expression profiles indicated miR-23a-3p and miR-181c-5p over-expression as associated with chemoresistance and poor PFS. RT-qPCR data confirmed upregulation of miR-23a-3p in tumors from chemoresistant HGSOC patients and its significant association with shorter PFS. In silico miR-23a-3p target prediction and comparative pathway analysis identified platinum drug resistance as the pathway with the highest number of miR-23a-3p target genes. Among them, APAF-1 emerged as the most promising, being downregulated in platinum-resistant patients and in HGSOC chemo-resistant cells. These results highlight miR-23a-3p as a potential biomarker for HGSOC platinum response and prognosis and the miR23a-3p/APAF1 axis as a possible target to overcome platinum-resistance. |
topic |
miRNA hypoxia ovarian cancer platinum response prognostic marker miR-23a-3p |
url |
https://www.mdpi.com/2072-6694/13/13/3358 |
work_keys_str_mv |
AT paolatodeschini comprehensiveprofilingofhypoxiarelatedmirnasidentifiesmir23a3poverexpressionasamarkerofplatinumresistanceandpoorprognosisinhighgradeserousovariancancer AT elisasalviato comprehensiveprofilingofhypoxiarelatedmirnasidentifiesmir23a3poverexpressionasamarkerofplatinumresistanceandpoorprognosisinhighgradeserousovariancancer AT chiararomani comprehensiveprofilingofhypoxiarelatedmirnasidentifiesmir23a3poverexpressionasamarkerofplatinumresistanceandpoorprognosisinhighgradeserousovariancancer AT vittoriaraimondi comprehensiveprofilingofhypoxiarelatedmirnasidentifiesmir23a3poverexpressionasamarkerofplatinumresistanceandpoorprognosisinhighgradeserousovariancancer AT francescociccarese comprehensiveprofilingofhypoxiarelatedmirnasidentifiesmir23a3poverexpressionasamarkerofplatinumresistanceandpoorprognosisinhighgradeserousovariancancer AT federicoferrari comprehensiveprofilingofhypoxiarelatedmirnasidentifiesmir23a3poverexpressionasamarkerofplatinumresistanceandpoorprognosisinhighgradeserousovariancancer AT germanatognon comprehensiveprofilingofhypoxiarelatedmirnasidentifiesmir23a3poverexpressionasamarkerofplatinumresistanceandpoorprognosisinhighgradeserousovariancancer AT sergiomarchini comprehensiveprofilingofhypoxiarelatedmirnasidentifiesmir23a3poverexpressionasamarkerofplatinumresistanceandpoorprognosisinhighgradeserousovariancancer AT mauriziodincalci comprehensiveprofilingofhypoxiarelatedmirnasidentifiesmir23a3poverexpressionasamarkerofplatinumresistanceandpoorprognosisinhighgradeserousovariancancer AT laurazanotti comprehensiveprofilingofhypoxiarelatedmirnasidentifiesmir23a3poverexpressionasamarkerofplatinumresistanceandpoorprognosisinhighgradeserousovariancancer AT antonellaravaggi comprehensiveprofilingofhypoxiarelatedmirnasidentifiesmir23a3poverexpressionasamarkerofplatinumresistanceandpoorprognosisinhighgradeserousovariancancer AT francoodicino comprehensiveprofilingofhypoxiarelatedmirnasidentifiesmir23a3poverexpressionasamarkerofplatinumresistanceandpoorprognosisinhighgradeserousovariancancer AT enricosartori comprehensiveprofilingofhypoxiarelatedmirnasidentifiesmir23a3poverexpressionasamarkerofplatinumresistanceandpoorprognosisinhighgradeserousovariancancer AT donnamdagostino comprehensiveprofilingofhypoxiarelatedmirnasidentifiesmir23a3poverexpressionasamarkerofplatinumresistanceandpoorprognosisinhighgradeserousovariancancer AT michelesamaja comprehensiveprofilingofhypoxiarelatedmirnasidentifiesmir23a3poverexpressionasamarkerofplatinumresistanceandpoorprognosisinhighgradeserousovariancancer AT chiararomualdi comprehensiveprofilingofhypoxiarelatedmirnasidentifiesmir23a3poverexpressionasamarkerofplatinumresistanceandpoorprognosisinhighgradeserousovariancancer AT elianabignotti comprehensiveprofilingofhypoxiarelatedmirnasidentifiesmir23a3poverexpressionasamarkerofplatinumresistanceandpoorprognosisinhighgradeserousovariancancer |
_version_ |
1721299756982992896 |